Jellagen Pty Ltd Company visited TÜBİTAK MRC Chemistry Institute

On 2 March 2015, Dr. Andrew Mearns Spragg, CEO of Jellagen Pty Ltd Company; which operates on medical technologies in the United Kingdom; and Selçuk Haydanlı, Factory Manager of Altaylar Medical Company, visited TÜBİTAK MRC Chemistry Institute to develop new joint projects under EU Horizon 2020 program. As a part of the visit, Dr. Serdar Sezer, Deputy Director of TÜBİTAK MRC Chemistry Institute, gave them a briefing about the ongoing and potential projects in medical field and the private sector – attended EU Horizon 2020 calls. The companies’ representatives made a presentation about potential cooperation projects, and then visited TÜBİTAK MRC Chemistry Institute’s laboratories to get information about the ongoing projects.